MARKET

QNRX

QNRX

Quoin Pharmaceuticals Ltd
NASDAQ
15.03
+1.61
+12.00%
After Hours: 14.33 -0.7 -4.66% 19:52 11/14 EST
OPEN
13.04
PREV CLOSE
13.42
HIGH
15.50
LOW
12.26
VOLUME
178.98K
TURNOVER
--
52 WEEK HIGH
48.30
52 WEEK LOW
5.01
MARKET CAP
12.61M
P/E (TTM)
-0.0316
1D
5D
1M
3M
1Y
5Y
1D
Promising Prospects for Quoin Pharmaceuticals: Buy Rating Backed by Innovative Developments and Pipeline Diversification
TipRanks · 2d ago
Quoin Pharmaceuticals Achieves Key Milestone in Rapamycin Delivery
TipRanks · 3d ago
Quoin Pharmaceuticals Shares Climb 21% On Topical Rapamycin Milestone
NASDAQ · 4d ago
US Stocks Mixed; Sea Shares Gain After Q3 Results
Benzinga · 4d ago
Quoin announces achievement of rapamycin target loadings
TipRanks · 4d ago
Quoin Pharmaceuticals Announces Achieves Target Loading Concentration For Its Two Topical Rapamycin Delivery Technologies.
Benzinga · 4d ago
Weekly Report: what happened at QNRX last week (1103-1107)?
Weekly Report · 5d ago
Quoin Pharmaceuticals Reports Q3 2025 Financial Results
TipRanks · 11/08 04:13
More
About QNRX
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

Webull offers Quoin Pharmaceuticals Ltd - ADR stock information, including NASDAQ: QNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNRX stock methods without spending real money on the virtual paper trading platform.